Average Co-Inventor Count = 17.76
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Galapagos Nv (12 from 116 patents)
2. Abbvie S.a.r.l. (6 from 15 patents)
3. Abbvie Overseas Sarl (5 from 5 patents)
12 patents:
1. 10988454 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
2. 10981890 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
3. 10844041 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
4. 10844042 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
5. 10829473 - Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
6. 10647717 - N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
7. 10259810 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
8. 10130622 - Compounds for treatment of cystic fibrosis
9. 9981910 - Substituted pyrrolidines and methods of use
10. 9890158 - N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
11. 9796719 - Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
12. 9796711 - [object Object]